<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Some wellness peptides will become widely available, HHS says — Live Feed</title><link>https://www.live-feeds.com/feed/some-wellness-peptides-will-become-widely-available-hhs-says</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/some-wellness-peptides-will-become-widely-available-hhs-says/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>HHS Eases Access to Unapproved Wellness Peptides</title><link>https://www.live-feeds.com/feed/some-wellness-peptides-will-become-widely-available-hhs-says</link><guid isPermaLink="false">https://www.live-feeds.com/feed/some-wellness-peptides-will-become-widely-available-hhs-says#u167893</guid><pubDate>Sun, 01 Nov 2026 12:20:34 +0000</pubDate><description>The U.S. Department of Health and Human Services announced a policy change allowing compounding pharmacies to temporarily provide six unapproved wellness peptides by prescription. The substances affected include BPC-157, TB-500, epitalon, MOTS-c, KPV, and semax. RFK Jr. utilized a shortcut to ease restrictions on these items, granting wider prescription access for individual patients under specific conditions. However, the department explicitly stated that the new policy does not establish the clinical safety or effectiveness of these peptide injections.Why it mattersCompounded drugs typically</description></item>
</channel></rss>